(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
65% of central corneas were completely clear at 3 months
(Cequa)
.05% Cyclosporine
(Restasis)
Improvement in visual acuity as early as day 56
(Cequa)
Symptom Improvement in the first 30 days
(Vevye)
Increase in Schirmer score of 10mm over vehicle in 6 mo (Restasis)
1-3% of pts. reported blurred vision and eye redness
(Miebo)
Patients stay on treatment longer then Restasis and Xiidra
(Cequa)
The first and only prescription drop that directly targets tear evaporation
Improvement in Schirmer Score at day 28
(Tyrvaya)
Relief from inflammation in the first 15 days
(Vevye)
Symptomatic Relief in 2 weeks in 2 out of 4 studies
(Xiidra)
Indicated for the treatment of the signs & symptoms of DED
(M, V, T, X)
Lifitegrast 5%
(Xiidra)
QID
(Miebo)
Blurred Vision was the most common ocular adverse reaction
(Miebo)
one month supply is 60 .25ml vials
(Cequa)
82% of patients reported sneezing
(Tyrvaya)
95% of patients experienced no or mild installation site pain (Cequa)
Improvement in corneal staining after just 14 days
(Cequa)
Throat irritation
13% of patients
(Tyrvaya)
.09% Cyclosporine
(Cequa)
Reduces the signs of dry eye by week 12 in some patients
(Xiidra)
.03mg of varenicline
(Tyrvaya)
30 day supply is 60 .2ml vials
(Xiidra)
When TYRVAYA has not been used for more than 5 days, re-prime with 1 spray into the air
Fre99.8% of patients reported no or mild stinging/burning
(Vevye)e!
